RE:RE:The offering -- Sedar
25 ADELAIDE STREET EAST SUITE 1900 TORONTO ONTARIO M5C 3A1
ENRICO MORETTI DESK: 416.867.8800 X203 CELL: 416.543.0729 EMAIL: ENRICO@BOYLECO.COM
FILED VIA SEDAR
October 13, 2021
Ontario Securities Commission
British Columbia Securities Commission
Alberta Securities Commission
Financial and Consumer Affairs Authority of Saskatchewan
Dear Ladies and Gentlemen:
Re: Ventripoint Diagnostics Ltd. (the “Issuer”)
SEDAR Project No. 03282779
Final Short Form Prospectus dated October 13, 2021 (the “Prospectus”) under
National Instrument 44-101, Multilateral Instrument 11-102 and National Policy 11-
202
We refer to the Prospectus of the Issuer.
We hereby consent to the use of our firm name and to the reference to our opinion under the headings
“Eligibility for Investment” and “Legal Matters” of the Prospectus and to the use of our firm name on
page (iii) and under the heading “Interests of Experts” of the Prospectus.
We confirm that we have read the Prospectus and have no reason to believe that there are any
misrepresentations in the information contained in the Prospectus that are derived from our opinion
referred to above or that is within our knowledge as a result of the services we performed in connection
with such opinion.
Yours very truly,
Boyle & Co. LLP